ZnO substituted 45S5 bioactive -glasses and glass -ceramics were prepared. In vitro bioactivity of bioactive glasses and glass -ceramics, before and after exposed to simulated body fluid (SBF) solution for different time periods, were investigated by fourier transform infrared (FTIR) reflectance spectrometer with measuring the pH and the concentrations of silicon, sodium, calcium, phosphorus and zinc ions in SBF solution. The density, micro hardness and flexural strength of bioactive glasses and glass -ceramics were measured. Experimental results show that in vitro bioactivity nearly remains same by doping 1% of ZnO by weight, but after that as well as ZnO content increases in vitro bioactivity decreases. Crystallization of bioactive glasses decreases in vitro bioactivity. The density, micro hardness and flexural strength of bioactive glass -ceramics are higher than their respective bioactive glasses and these are also increasing with the increase of ZnO content.
tissue bond. Some authors (Clupper, et al., 2001) argued that the crystallization of 45S5 bioactive glass has a little effect on the ability of this bioactive glass to form a tissue bond.
A first aim of the present investigation is to determine the bioactive behaviour of ZnO substituted 45S5 bioactive glasses and glass -ceramics since zinc is a trace element that shows stimulatory effects on bone formation (Rahaman, et al., 2011) . A further aim of this investigation is to determine the density, micro hardness and flexural strength of these bioactive glasses and glass -ceramics.
Experimental

Preparation of Bioactive Glasses and Glass -ceramics
The bioactive glasses, the compositions of which are given in Table 1 , were prepared by employing normal melting and annealing techniques. For preparation of bioactive glasses: fine grained quartz (Merck, India) was used as the source of SiO 2 , anhydrous sodium carbonate [Na 2 CO 3 ] (Merck, India) was used as the source of Na 2 O, anhydrous calcium carbonate [CaCO 3 ] (Merck, India) was used as the source of CaO, ammonium dehydrogenate orthophosphate [NH 4 H 2 PO 4 ] (Merck, India) was used as the source of P 2 O 5 while ZnO (Merck, India) was added as such. All the materials were of analytical grade chemicals and used without further purification. The weighed batches were homogeneously mixed using an agate mortar and pestle before melting in alumina crucibles for 3 hours in an electric furnace at the temperature 1400 ± 10 °C. The homogeneous melts were cast into preheated stainless steel moulds of the required dimensions. The prepared bioactive glass samples were directly transferred to a regulated muffle furnace at the temperature 500 °C for annealing. After 1 h, the muffle furnace was left to cool to room temperature at a rate of 30 °C/h.
In order to obtain the bioactive glass -ceramics, the bioactive glass samples were heated in the muffle furnace in two step regime at the deduced temperatures and times as shown in Table 2 . These temperatures were obtained from differential thermal analysis (DTA) of bioactive glasses. Each bioactive glass sample was first heated slowly to the nucleation temperature for the formation of sufficient nuclei sites and after holding for the definite time, was then further heated to reach the crystallization temperature for performing the perfect crystal growth process and after a second hold for the specific time, the sample was left to cool inside the muffle furnace to room temperature at a rate of 20 °C/h.
Physical Analysis
In order to determine glass nucleation and crystallization temperature, differential thermal analysis (DTA) was carried out on bioactive glass samples. Fine powder of bioactive glasses was made using an agate mortar and pestle and analyzed using a differential thermal analyzer (Perkin Elmer Diamond, USA) at a heating rate of 10 0 C/ min under a stream of argon atmosphere using alumina as a reference material. DTA was carried out from the temperature 300 °C to 900 °C. Identification of the crystalline phases after heat -treatment of bioactive glass samples was carried out by X -ray diffraction (XRD) analysis. Fine powder of bioactive glass -ceramics was made using an agate mortar and pestle and examined using a X -ray diffractometer (Bruker AXS, Model: D8 Advance, UK), adopting Ni filter and Cu target with voltage of 40 KV and a current of 25 mA. The XRD patterns were recorded in a 2θ range of 10 -70°. The JCPDS -International Center for Diffraction Data Cards was used as a reference data for the interpretation of XRD patterns in the present work.
In Vitro Bioactivity Tests
In 1991 Kokubo developed simulated body fluid (SBF), which has become the most widely used solution for in vitro investigation of bioactivity of bioactive materials by providing conditions very close to those found in vivo. The ion concentration of simulated body fluid is nearly equal to that of human blood plasma and is given in Table 3 (Kokubo, et al., 2006) . The simulated body fluid (SBF) solution was prepared by dissolving the required amounts of reagent grade chemicals (Merck, India), the sodium chloride [NaCl] We carried out in vitro studies by soaking polished pieces with dimension 10 mm x 10 mm x 2 mm of each bioactive glass and glass -ceramic sample in 50 ml SBF solution, at the temperature 37 °C, for 1, 3, 7 and 15 days. After soaking, the samples were filtered, rinsed with distilled water, and dried in an air oven at the temperature 150 °C for 24 hours. Identification of the structural groups of bioactive glass and glass -ceramic samples before and after soaking in SBF solution was carried out by fourier transform infrared (FTIR) reflectance spectrometric investigation. Fine powder of bioactive glasses and glass -ceramics was made using an agate mortar and pestle and investigated by fourier transform infrared reflectance spectrometer (Impact 420, Nicolet Instruments, USA) at 2 cm -1 resolution with reference to KBr. FTIR spectra were recorded between wavenumber 1400 and 400 cm -1
. The elemental concentration of the SBF solution, before and after soaking of bioactive glass and glass -ceramic samples, were examined by atomic absorption spectroscopy (AAS, Model Spectra AA, 220FS). The pH of the SBF solution, before and after soaking of bioactive glass and glass -ceramic samples, was recorded by pH meter (Thermo Orion, Model: 720A, USA).
Density and Mechanical Properties Measurements
Archimedes principle was employed to obtain the density of bioactive glass and glass -ceramic samples using distilled water as buoyant. All the weight measurements have been made using a digital balance (Sartorius, Model: BP221S, USA) having an accuracy of ± 0.0001 g. Density of sample was obtained employing the relation (1) (Rajendran, et al., 2002) as given below:
( 1) where is the weight of sample in air, is the weight of sample in buoyant and is the density of buoyant. Micro indentations were made on the polished surfaces of bioactive glass and glass -ceramic specimens using a diamond Vickers indenter on a micro hardness testing machine (Future -Tech Corp, Tokyo, Model FM -7e, Japan). The size of the specimen was 10 mm x 10 mm x 10 mm according to ASTM Standard: C730 -98. The indentations have been made for loads ranging between 30 mN and 2000 mN, applied at a velocity of 1 mm/s and allowed to equilibrate for 15 seconds before measurement. Micro hardness (GPa) of specimen is calculated using the formula (2) (Michel, et al., 2004) as given below:
where (N) is the applied load on specimen and (m) is the diagonal of the impression.
Three points flexural strength tests were carried out for polished bioactive glass and glass -ceramic specimens, using a universal testing machine (Instron Corp, Canton, MA, Model 5500R, USA). The size of the specimen was 4 mm x 4 mm x 50 mm according to ASTM Standard: C158 -02. The load was applied over a 40 mm span and at the mid -point of the 4 mm x 40 mm surface using a cross -head speed of 0.5 mm/min. Flexural Strength of specimen is calculated using the formula (3) (Chen, et al., 2006) as given below:
where is the load at which specimen being fractured, is the length of specimen over which the load is applied, is the width of specimen, and is the height of specimen.
Results
Physical Analysis
Differential Thermal Analysis (DTA)
The differential thermal analysis (DTA) plots of bioactive glasses are shown in Figure 1 . The DTA plots indicate that the incorporation of ZnO content in the base bioactive glass (45S5) causes a decrease in its exothermic peak temperature. The endothermic peak temperature of the base bioactive glass (45S5) also decreases with the addition of ZnO content in it but decrease in endothermic peak temperature is minor.
The X -Ray Diffraction (XRD) Analysis
The X -ray diffraction (XRD) patterns for bioactive glass -ceramics are shown in Figure 2 . The XRD patterns of all the bioactive glass -ceramics show the presence of crystalline phases of sodium calcium silicate [Na 2 Ca 2 Si 3 O 9 (card number: PDF # 01 -1078 & PDF # 02 -0961), Na 2 CaSi 3 O 8 (card number: PDF # 12 -0671)].
In Vitro Bioactivity Tests
Fourier Transform Infrared (FTIR) Reflectance Spectrometric Investigation
The fourier transform infrared (FTIR) reflectance spectra of bioactive glass 45S5 and its glass -ceramic 45S5C, before and after soaking in simulated body fluid (SBF) solution for a period of 1, 3, 7, and 15 days are given in Figure 3 . The FTIR reflectance spectra of bioactive glass 45S5 before soaking in SBF solution ( Figure 3A Following changes were observed in the FTIR reflectance spectra of bioactive glass 45S5 at various reaction times ( Figure 3A ). After soaking for 1 day in SBF solution peak at wavenumber 471 cm -1 shifted to lower wavenumber at 461 cm -1 and peak at wavenumber 1100 cm -1 shifted to higher wavenumber at 1125 cm -1 with decreasing their intensity, while the peak at wavenumber 930 cm -1 had disappeared. Appearance of new peaks at wavenumbers 557, 607, 794, 871, 1050, and 1250 cm -1 were observed. After 3 days the intensity of peaks at wavenumbers 557, 794, 1125, 1250 cm -1 decreased while the intensity of the peaks at wavenumbers 607, 871, 1050 cm -1 increased. After 7 days peak at wavenumber 471 cm -1 had disappeared. The appearance of peak at wavenumber 527 cm -1 was observed. After 15 days, peaks at wavenumbers 527, 607, 871, 1050 cm -1 were dominant in the FTIR reflectance spectra. Similar changes were observed in the FTIR reflectance spectra of bioactive glass -ceramic 45S5C at various reaction times ( Figure 3B ). Additional peaks at wavenumbers 580, 650 and 1041 cm -1 in bioactive glass -ceramic 45S5C had disappeared after soaking for 1 day in SBF solution.
Careful inspection of FTIR reflectance spectra of all the ZnO substituted bioactive glasses (Z1, Z2, Z3 and Z4) in comparison with the base bioactive glass (45S5) reveals minor or limited variation of the positions and intensities of the reflectance peaks. The main differences can be summarized in bioactive glasses, where there was a time delay in the formation of peaks at wavenumbers 527 and 607 cm -1
. After soaking for 15 days in SBF solution ( Figure 4A ) it was found that the intensity of peak at these wavenumbers nearly remains same by doping of 1% ZnO by weight with respect to parent bioactive glass (45S5), but afterwards as well as ZnO content increases a decrease in intensity was observed. The FTIR reflectance spectra of bioactive glasses and glass -ceramics after soaking for 15 days in SBF solution (Figure 4) shows that peaks at wavenumbers 527 and 607 cm -1 was found less intense in the bioactive glass -ceramics than their respective bioactive glasses.
Ion Release Analysis
Variations of Si, Na, Ca, P and Zn concentration in simulated body fluid (SBF) solution that was taken before and after soaking of bioactive glasses and glasses -ceramics for a period of 1, 3, 7 and 15 days, are shown in Figure 5 . As can be observed in all cases that Si concentration in SBF solution increased during first 7 days of soaking and then a slight decrease was obtained. Na concentration increased rapidly during first 3 days of soaking and then it attains nearly a constant value where as Ca concentration increased during first day of soaking and then it decreased continuously. Increase in Zn concentration and a decrease in P concentration were also observed. It was also observed that the addition of ZnO in the base bioactive glass (45S5) decreases the leaching rate of ions and crystallization of bioactive glasses also decreases the leaching rate of ions.
pH Measurements
The variation in pH values of simulated body fluid (SBF) solution that was taken before and after soaking of bioactive glasses and glasses -ceramics for a period of 1, 3, 7 and 15 days, is shown in Figure 6 . The pH value of SBF solution increased during first 3 days of soaking and then it attained nearly a constant value in all cases. It was also observed that the addition of ZnO in the base bioactive glass (45S5) causes an initial decrease in the pH value. Crystallization of bioactive glasses also decreases the initial pH value of SBF solution.
Density and Mechanical Properties Measurements
Experimental values of density, micro hardness and flexural strength of bioactive glasses and glass -ceramics are given in Table 4 . It has been observed that the increase of ZnO in the base bioactive glass (45S5) causes an increase in its density, micro hardness and flexural strength. It also has been observed that the density, micro hardness and flexural strength of bioactive glass -ceramics are higher than their respective bioactive glasses.
Discussions
Physical Analysis
Differential Thermal Analysis (DTA)
In the differential thermal analysis (DTA) plots of bioactive glasses (Figure 1 ) endothermic peaks show the nucleation region and the exothermic peaks correspond to the crystallization process. It has been reported that addition of ZnO decreases the viscosity of silicate glasses (Doremus, 1994) . Increasing the content of ZnO in the base bioactive glass (45S5) resulted in the movement of endothermic as well as exothermic peaks to lower temperatures. This can be attributed to the decrease of viscosity with the increase of ZnO content in the base bioactive glass (45S5) (Alizadeh, et al., 2000) .
X -Ray Diffraction (XRD) Analysis
The XRD patterns of all the bioactive glass -ceramics show the presence of crystalline phases. The reason for the ease of crystallization of bioactive glasses can be correlated with the presence of silicate and phosphate network, as well as the possible phase separation even in micro scale of the two phases on heat -treatment. It is well known that the addition of a few percentages of P 2 O 5 to silicate glass compositions, promotes the volume nucleation and glass -ceramic formation (ElBatal, et al., 2008) . There is some evidence for precipitation of phosphate crystals which subsequently act as heterogeneous nucleation sites for the subsequent crystallization of the major phases, although the detailed role of P 2 O 5 remains to be discussed (James, 1995) . Previous studies (Hench, et al., 1971 , Hench, et al., 1973 , Mastelaro, et al., 2000 have shown that the heat -treatment of 45S5 bioactive glass at a nucleation temperature of 550 °C and followed by heating at a crystallization temperature of 680 °C produces a bioactive glass -ceramic containing the sodium calcium silicate [Na 2 Ca 2 Si 3 O 9 ] as a main crystalline phase. In all the bioactive glass -ceramics sodium calcium silicate [Na 2 Ca 2 Si 3 O 9 & Na 2 CaSi 3 O 8 ] is present as a main crystalline phase (Figure 2 ). The studied bioactive glass -ceramics did not contain Zn as separate crystalline phases. This can be related to their relatively low content in the bioactive glasses composition.
In Vitro Bioactivity Tests
Fourier Transform Infrared (FTIR) Reflectance Spectrometric Investigation
The fourier transform infrared (FTIR) reflectance spectra of bioactive glasses and glass -ceramics before immersion in simulated body fluid (SBF) solution reveal Si -O -Si bending (500 -400 cm ) and Si -O -Si stretching (asymmetric) (1200 -970 cm -1 ) bands, which are known and accepted to be mainly characteristic of silicate network (Serra, et al., 2002 , Marchi, et al., 2005 , Wang, et al., 2011 . This may be attributed to the presence of major SiO 2 as a basic building constituent. The FTIR reflectance spectra of bioactive glasses and glass -ceramics did not show separate bands to the presence of phosphate network and this may be due to the limited percentage of P 2 O 5 . The FTIR reflectance spectra of bioactive glass -ceramics also, show the additional bands at wavenumbers 650 -619 cm -1 and 580 -570 cm -1 which are due to the presence of sodium calcium silicate crystalline phase (ElBatal, et al., 2003) . The FTIR reflectance spectra of bioactive glasses and glass -ceramics after soaking in simulated body fluid (SBF) solution for different times reveal Si -O -Si stretching (symmetric) (820 -770 cm ) bands are attributed due to presence of HCA layer (Filgueiras, et al., 1993 , Filho, et al., 1996 , Peitl, et al., 2001 . Intensity of silica -rich layer and CaO -P 2 O 5 layer goes on decreasing but the intensity of HCA layer increases with time in all cases after soaking for 1 day in SBF solution. Hench et al. were the first to detail a number of sequential steps for in vitro and in vivo reactivity of silicate glasses that are responsible for the tissue bonding ability of these glasses. Briefly, these involve cation release from the glass with consequential increase in pH of solution, formation of silica -rich layer and precipitation of a CaO -P 2 O 5 rich layer that further crystallizes as HCA layer (Hench, 1991 , Branda, et al., 1996 , Balamurugan, et al., 2007 . The degree of bioactivity in bioactive material is usually expressed by the formation of HCA surface. Finally, the FTIR reflectance spectra of bioactive glasses after soaking for 15 days in a SBF solution ( Figure 4A) indicates that the addition of 1% of ZnO by weight in the base bioactive glass (45S5) shows no effect on the formation of HCA layer but after that as well as ZnO content increases a decrease in the formation of HCA layer was observed. This can be due to release of Si from the base bioactive glass (45S5) decreases with increasing of ZnO content in it since ZnO enhances the chemical stability of silicate glasses (ElBatal, et al., 2010) . Therefore, the suppression of the formation of silica -rich layer leads to the suppression of CaO -P 2 O 5 layer and hence suppression of the formation of HCA surface. The FTIR reflectance spectra of bioactive glasses and glass -ceramics after soaking for 15 days in a SBF solution ( Figure  4) shows that the formation of HCA layer on bioactive glass -ceramics are significantly less than their respective bioactive glasses. This phenomenon is explained by considering that the amorphous phase is usually more prone to ion leaching phenomena than crystalline phases (Verne, et al., 2009 ).
Ion Release Analysis
The quantitative determination of Si, Na, Ca, P and Zn ions in simulated body fluid (SBF) solution for various times ( Figure 5 ) is important to understand the kinetics of surface reactions in bioactive glasses and glassceramics. During initial period of soaking faster release of Ca ions increases the concentration of Ca ions. Decrease in Ca concentration is due to formation of CaO -P 2 O 5 layer. The decrease in P concentration with a simultaneous increase in Si concentration is consistent with the formation of CaO -P 2 O 5 layer. The participation of Zn in the nucleation process can be ascertained by the observed variation in its concentration with soaking time.
pH Measurements
During initial period of soaking, faster release of Ca and Na ions increased the pH value, but after that pH attained nearly a constant value since the rate of release of Na ion decreased (Figure 6 ).
Density and Mechanical Properties Measurements
The increase of ZnO content in the base bioactive glass (45S5) leads to an increase its density because of replacement of a lighter element, Si (density = 2.33 g/cm 3 ) with a heavier element, Zn (density = 7.14 g/cm 3
). The increase of ZnO content in the base bioactive glass (45S5), also leads to an increase its micro hardness and flexural strength. This is easily understood that the more the density of glass, the more the compactness of glass structure, and consequently, the more micro hardness and flexural strength. The density, micro hardness and flexural strength of bioactive glass -ceramics are higher than their respective bioactive glasses due to densification.
Conclusions
In the present investigation, a comparative study was made on physical, bioactive and mechanical properties of ZnO substituted 45S5 bioactive glasses and glass -ceramics. The following conclusions are obtained from this investigation:
(1). Increasing the ZnO content in 45S5 bioactive glass decreases its glass crystallization temperature. Increase of ZnO content in 45S5 bioactive glass also decreases its glass nucleation temperature but decrease in glass nucleation temperature is small. There is no effect on the formation of hydroxyl -carbonate apatite (HCA) layer by addition of 1% of ZnO by weight in 45S5 bioactive glass, but increasing of ZnO content more than 1% decreases the formation of HCA layer. Increasing the ZnO content in 45S5 bioactive glass enhances its chemical durability, density, micro hardness and flexural strength.
(2). Controlled crystallization of bioactive glasses produced crystalline phases of sodium calcium silicate [Na 2 Ca 2 Si 3 O 9 and Na 2 CaSi 3 O 8 ]. Crystallization of bioactive glasses shows a slight retardation in the formation of HCA layer, but enhances their chemical durability, density, micro hardness and flexural strength. 
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